John E Abordo, DPM
Podiatry · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
Offices
4 locations · Golden Valley Health Centers · Provident Primary Care Inc
Hospitals listed: 058233 · Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abordo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$52,026
Medicare paid this office $52,026 for 101 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 66 | $19,165 | $93 |
| Removal of fingernails or toenails, 6 or more nails | 43 | $4,022 | $33 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $3,917 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,620 | $65 |
| New patient visit (45+ min) | 11 | $1,278 | $116 |
Procedures Medicare counted
| Removal of nail tissue | 180 | More than 74% of doctors who do this |
| Removal of tissue | 64 | More than 81% of doctors who do this |
| Removal or shaving of skin growth | 30 | More than 75% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
101 Original Medicare patients in 2024. Average age 69 · Women 53% · Also on Medicaid 66% · Health risk score 2.24. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 61% · Coronary heart disease 42% · Chronic kidney disease 38% · COPD 27% · Heart failure 24% · Depression 22% · Atrial fibrillation 21% · Stroke 14%.
The office billed $141,476, Medicare allowed $67,552 and paid $52,026; for 613 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 101 | 613 | 69 | 2.24 | $141,476 | $52,026 |
| 2023 | 127 | 822 | 68 | 1.84 | $207,580 | $77,029 |
| 2022 | 123 | 754 | 69 | 2.41 | $206,255 | $97,841 |
| 2021 | 137 | 1,030 | 69 | 2.49 | $281,321 | $156,224 |
| 2020 | 144 | 793 | 68 | 2.09 | $176,437 | $74,214 |
| 2019 | 199 | 564 | 71 | 2.52 | $114,576 | $43,808 |
| 2018 | 108 | 270 | 68 | 2.28 | $69,352 | $23,937 |
| 2017 | 51 | 479 | 65 | 2.43 | $117,425 | $54,030 |
| 2016 | 28 | 454 | 60 | 3.72 | $109,680 | $55,531 |
| 2015 | 37 | 132 | 63 | 1.91 | $27,978 | $10,956 |
| 2014 | 31 | 68 | 64 | 2.38 | $44,239 | $15,075 |
| 2013 | 20 | 37 | 61 | 2.52 | $26,596 | $9,121 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 80 | $21,541 | $94 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $6,328 | $77 |
| Removal of fingernails or toenails, 6 or more nails | 51 | $3,548 | $34 |
| New patient visit (45+ min) | 26 | $3,196 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,458 | $63 |
2022: 4 services
| Return visit (30+ min) | 74 | $21,875 | $94 |
| New patient visit (45+ min) | 19 | $2,471 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,457 | $55 |
| Removal of fingernails or toenails, 6 or more nails | 38 | $2,327 | $31 |
2021: 5 services
| Return visit (30+ min) | 89 | $27,635 | $97 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $5,622 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 57 | $3,882 | $34 |
| New patient visit (45+ min) | 18 | $2,377 | $132 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,453 | $56 |
2020: 9 services
| Return visit (30+ min) | 80 | $20,506 | $79 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $4,982 | $84 |
| Extended office or other outpatient service, first hour | 42 | $4,060 | $97 |
| Removal of fingernails or toenails, 6 or more nails | 42 | $3,604 | $35 |
| New patient visit (45+ min) | 14 | $1,535 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,187 | $57 |
| New patient visit (30+ min) | 11 | $936 | $85 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $803 | $47 |
| Hemoglobin a1c level | 33 | $317 | $10 |
2019: 6 services
| Return visit (30+ min) | 79 | $14,119 | $82 |
| Extended office or other outpatient service, first hour | 37 | $3,271 | $88 |
| Removal of fingernails or toenails, 6 or more nails | 40 | $2,868 | $36 |
| Hemoglobin a1c level | 94 | $1,099 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,056 | $59 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $631 | $45 |
2018: 4 services
| Return visit (30+ min) | 39 | $5,469 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,533 | $90 |
| Removal of fingernails or toenails, 6 or more nails | 16 | $898 | $33 |
| Hemoglobin a1c level | 31 | $364 | $12 |
2017: 3 services
| Return visit (30+ min) | 12 | $1,370 | $86 |
| Short return visit (20+ min) | 11 | $789 | $56 |
| Hemoglobin a1c level | 13 | $170 | $13 |
2016: 1 service
| Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $555 | $40 |
Medicaid work
$265,252 in 2024
Medicaid paid $265,252 for 3,278 billed services this clinician did in 2024, up to 135 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,336 | $195,021 |
| Return visit (30+ min) | 1,303 | $57,823 |
| Debridement of nail(s) by any method(s); 6 or more | 585 | $11,466 |
| HOME/RES VISIT EST PATIENT MOD MDM 40 MINUTES | 15 | $942 |
| Short return visit (20+ min) | 39 | $0 |
| 2024 | 3,278 | 5 | 135 | $265,252 |
| 2023 | 5,078 | 5 | 162 | $416,239 |
| 2022 | 3,432 | 3 | 139 | $298,807 |
| 2021 | 4,806 | 6 | 148 | $398,050 |
| 2020 | 4,466 | 6 | 121 | $311,649 |
| 2019 | 3,638 | 7 | 134 | $292,021 |
| 2018 | 4,184 | 7 | 249 | $370,360 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,610 | $225,905 |
| Return visit (30+ min) | 2,638 | $172,432 |
| Debridement of nail(s) by any method(s); 6 or more | 711 | $14,492 |
| HOME/RES VISIT EST PATIENT MOD MDM 40 MINUTES | 31 | $1,911 |
| Short return visit (20+ min) | 88 | $1,500 |
2022
| Clinic visit/encounter, all-inclusive | 1,113 | $152,550 |
| Return visit (30+ min) | 1,893 | $137,029 |
| Debridement of nail(s) by any method(s); 6 or more | 426 | $9,228 |
2021
| Clinic visit/encounter, all-inclusive | 1,816 | $256,043 |
| Return visit (30+ min) | 2,159 | $127,743 |
| Debridement of nail(s) by any method(s); 6 or more | 523 | $7,700 |
| Short return visit (20+ min) | 107 | $6,563 |
| Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when any of the 3 components are completed) (DM) | 182 | $0 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 19 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,502 | $195,717 |
| Short return visit (20+ min) | 2,374 | $96,065 |
| Return visit (30+ min) | 311 | $18,831 |
| Debridement of nail(s) by any method(s); 6 or more | 197 | $584 |
| Short return visit | 34 | $452 |
| Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when any of the 3 components are completed) (DM) | 48 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,251 | $158,283 |
| Short return visit (20+ min) | 1,843 | $107,434 |
| Return visit (30+ min) | 313 | $24,128 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 15 | $1,430 |
| Hemoglobin A1C level | 44 | $442 |
| Debridement of nail(s) by any method(s); 6 or more | 157 | $305 |
| Foot examination performed (includes examination through visual inspection, sensory exam with monofilament, and pulse exam - report when any of the 3 components are completed) (DM) | 15 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,980 | $245,870 |
| Short return visit (20+ min) | 1,869 | $99,744 |
| Return visit (30+ min) | 173 | $15,847 |
| Debridement of nail(s) by any method(s); 6 or more | 85 | $3,919 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 39 | $3,718 |
| REMOVAL OF NAIL PLATE | 26 | $1,132 |
| Hemoglobin A1C level | 12 | $130 |
Drugs they prescribed that Part D paid
$24,104
Pharmacies billed $24,104 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
640 generic and 15 brand-name prescriptions · $24,104 in drug cost · 79 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 278 | $7,327 | $26 |
| Ciclopirox | 118 | $3,770 | $32 |
| Econazole Nitrate | 30 | $2,047 | $68 |
| Lidocaine | 15 | $1,522 | $101 |
| Gabapentin | 93 | $371 | $4 |
See all 8 drugs
| Ketoconazole | 278 | $7,327 | $26 |
| Ciclopirox | 118 | $3,770 | $32 |
| Econazole Nitrate | 30 | $2,047 | $68 |
| Lidocaine | 15 | $1,522 | $101 |
| Gabapentin | 93 | $371 | $4 |
| Cephalexin | 26 | $183 | $7 |
| Sulfamethoxazole-Trimethoprim | 31 | $129 | $4 |
| Amoxicillin-Clavulanate Potass | 13 | $78 | $6 |
Year by year
| 2024 | 655 | 234 | None | 2% | $24,104 |
| 2023 | 696 | 231 | None | 2% | $48,998 |
| 2022 | 668 | 199 | 2% (11) | None | $41,268 |
| 2021 | 698 | 237 | None | None | $35,207 |
| 2020 | 833 | 275 | 2% (16) | None | $31,993 |
| 2019 | 902 | 305 | 2% (20) | None | $39,807 |
| 2018 | 771 | 313 | 3% (20) | 1% | $38,459 |
| 2017 | 861 | 298 | 3% (23) | None | $42,394 |
| 2016 | 730 | 287 | 3% (20) | None | $71,627 |
| 2015 | 938 | 345 | 2% (15) | None | $144,547 |
| 2014 | 910 | 348 | 4% (32) | None | $45,561 |
| 2013 | 1,022 | 291 | 2% (25) | None | $31,095 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Ketoconazole | 271 | $12,091 | $45 |
| Ciclopirox | 128 | $5,088 | $40 |
| Econazole Nitrate | 32 | $4,584 | $143 |
| Lidocaine | 20 | $3,896 | $195 |
| Gabapentin | 98 | $784 | $8 |
| Sulfamethoxazole-Trimethoprim | 37 | $377 | $10 |
| Terbinafine | 13 | $227 | $17 |
| Diclofenac | 12 | $226 | $19 |
| Cephalexin | 16 | $153 | $10 |
2022: 9 drugs
| Ketoconazole | 285 | $17,291 | $61 |
| Ciclopirox | 129 | $4,089 | $32 |
| Econazole Nitrate | 13 | $1,234 | $95 |
| Gabapentin | 81 | $914 | $11 |
| Cephalexin | 33 | $341 | $10 |
| Sulfamethoxazole-Trimethoprim | 34 | $240 | $7 |
| Terbinafine | 11 | $130 | $12 |
| Ciprofloxacin | 12 | $112 | $9 |
| Hydrocodone-Acetaminophen | 11 | $62 | $6 |
2021: 7 drugs
| Ketoconazole | 337 | $17,392 | $52 |
| Econazole Nitrate | 30 | $5,405 | $180 |
| Ciclopirox | 82 | $2,592 | $32 |
| Gabapentin | 70 | $437 | $6 |
| Cephalexin | 36 | $242 | $7 |
| Sulfamethoxazole-Trimethoprim | 42 | $167 | $4 |
| Ciprofloxacin | 13 | $143 | $11 |
2020: 9 drugs
| Ketoconazole | 387 | $17,780 | $46 |
| Ciclopirox | 149 | $4,443 | $30 |
| Santyl | 14 | $4,077 | $291 |
| Econazole Nitrate | 16 | $2,234 | $140 |
| Gabapentin | 99 | $336 | $3 |
| Cephalexin | 35 | $203 | $6 |
| Sulfamethoxazole-Trimethoprim | 31 | $157 | $5 |
| Terbinafine | 13 | $126 | $10 |
| Hydrocodone-Acetaminophen | 15 | $64 | $4 |
2019: 9 drugs
| Ketoconazole | 455 | $22,217 | $49 |
| Ciclopirox | 158 | $4,458 | $28 |
| Econazole Nitrate | 23 | $2,710 | $118 |
| Gabapentin | 98 | $289 | $3 |
| Sulfamethoxazole-Trimethoprim | 39 | $247 | $6 |
| Terbinafine | 17 | $213 | $13 |
| Cephalexin | 22 | $185 | $8 |
| Hydrocodone-Acetaminophen | 19 | $107 | $6 |
| Ibuprofen | 12 | $76 | $6 |
2018: 8 drugs
| Ketoconazole | 428 | $26,217 | $61 |
| Ciclopirox | 147 | $4,640 | $32 |
| Econazole Nitrate | 15 | $1,949 | $130 |
| Gabapentin | 70 | $314 | $4 |
| Hydrocodone-Acetaminophen | 19 | $216 | $11 |
| Cephalexin | 18 | $172 | $10 |
| Sulfamethoxazole-Trimethoprim | 15 | $80 | $5 |
| Ibuprofen | 11 | $53 | $5 |
2017: 7 drugs
| Ketoconazole | 368 | $23,695 | $64 |
| Econazole Nitrate | 55 | $11,440 | $208 |
| Ciclopirox | 140 | $4,659 | $33 |
| Gabapentin | 137 | $480 | $4 |
| Hydrocodone-Acetaminophen | 22 | $149 | $7 |
| Sulfamethoxazole-Trimethoprim | 29 | $123 | $4 |
| Cephalexin | 18 | $109 | $6 |
2016: 9 drugs
| Econazole Nitrate | 219 | $49,625 | $227 |
| Ketoconazole | 129 | $9,892 | $77 |
| Ciclopirox | 154 | $4,743 | $31 |
| Gabapentin | 57 | $284 | $5 |
| Hydrocodone-Acetaminophen | 19 | $186 | $10 |
| Cephalexin | 24 | $157 | $7 |
| Ibuprofen | 21 | $113 | $5 |
| Sulfamethoxazole-Trimethoprim | 19 | $85 | $4 |
| Naproxen | 11 | $80 | $7 |
2015: 7 drugs
| Econazole Nitrate | 482 | $132,658 | $275 |
| Ciclopirox | 236 | $8,288 | $35 |
| Gabapentin | 63 | $489 | $8 |
| Sulfamethoxazole-Trimethoprim | 30 | $161 | $5 |
| Ibuprofen | 26 | $156 | $6 |
| Cephalexin | 25 | $155 | $6 |
| Hydrocodone-Acetaminophen | 13 | $91 | $7 |
2014: 7 drugs
| Econazole Nitrate | 509 | $37,354 | $73 |
| Ciclopirox | 147 | $4,872 | $33 |
| Gabapentin | 64 | $402 | $6 |
| Hydrocodone-Acetaminophen | 24 | $248 | $10 |
| Cephalexin | 28 | $191 | $7 |
| Ibuprofen | 29 | $181 | $6 |
| Sulfamethoxazole-Trimethoprim | 23 | $144 | $6 |
2013: 19 drugs
| Econazole Nitrate | 373 | $11,792 | $32 |
| Ciclopirox | 54 | $1,267 | $23 |
| Fenofibrate | 14 | $964 | $69 |
| Clopidogrel | 11 | $357 | $32 |
| Metformin | 26 | $246 | $9 |
| Pravastatin | 17 | $205 | $12 |
| Enalapril Maleate | 25 | $194 | $8 |
| Omeprazole | 24 | $194 | $8 |
| Gabapentin | 25 | $174 | $7 |
| Glipizide | 21 | $144 | $7 |
| Sulfamethoxazole-Trimethoprim | 23 | $137 | $6 |
| Alendronate | 18 | $134 | $7 |
| Ibuprofen | 23 | $127 | $6 |
| Hydrocodone-Acetaminophen | 22 | $111 | $5 |
| Lisinopril | 21 | $103 | $5 |
| Hydrochlorothiazide | 19 | $68 | $4 |
| Atenolol | 12 | $57 | $5 |
| Metoprolol | 11 | $53 | $5 |
| Ranitidine | 11 | $52 | $5 |
Money from drug and device companies
$1,024 in 2025
| 2025 | 5 | 31 | None | $1,024 |
| 2024 | 6 | 16 | None | $326 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 2 | 2 | None | $102 |
| 2021 | 1 | 2 | None | $315 |
| 2020 | 1 | 1 | None | $59 |
| 2019 | 4 | 4 | None | $239 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| MIMEDX Group | None | $703 | 14 payments
|
| Smith+Nephew | Collagenase Santyl | $137 | 14 payments
|
| PolyNovo North America | Novosorb Btm | $88 | 1 payment
|
| Cornerstone Medical Associates | None | $87 | 1 payment
|
| Orthofix Medical | Physio-Stim | $10 | 1 payment
|
See all 31 published payments
| Smith+Nephew | Meals · 2025-12-15 | Collagenase Santyl | $5 |
| Smith+Nephew | Meals · 2025-11-25 | Collagenase Santyl | $12 |
| Cornerstone Medical Associates | Meals · 2025-11-19 | None | $87 |
| MIMEDX Group | Meals · 2025-11-14 | None | $11 |
| MIMEDX Group | Meals · 2025-11-08 | None | $8 |
| Orthofix Medical | Meals · 2025-10-22 | Physio-Stim | $10 |
| Smith+Nephew | Meals · 2025-10-21 | Collagenase Santyl | $9 |
| MIMEDX Group | Meals · 2025-10-18 | None | $12 |
| MIMEDX Group | Meals · 2025-10-17 | None | $29 |
| MIMEDX Group | Travel · 2025-10-02 | None | $39 |
| MIMEDX Group | Travel · 2025-10-02 | None | $284 |
| Smith+Nephew | Meals · 2025-09-25 | Collagenase Santyl | $7 |
| Smith+Nephew | Meals · 2025-09-18 | Collagenase Santyl | $4 |
| MIMEDX Group | Meals · 2025-08-01 | None | $8 |
| Smith+Nephew | Meals · 2025-08-01 | Stravix Pl | $13 |
| MIMEDX Group | Meals · 2025-07-19 | None | $11 |
| Smith+Nephew | Meals · 2025-07-09 | Collagenase Santyl | $4 |
| Smith+Nephew | Meals · 2025-06-30 | Collagenase Santyl | $9 |
| MIMEDX Group | Meals · 2025-06-26 | None | $13 |
| PolyNovo North America | Meals · 2025-05-29 | Novosorb Btm | $88 |
| Smith+Nephew | Meals · 2025-05-20 | Collagenase Santyl | $9 |
| Smith+Nephew | Meals · 2025-05-14 | Collagenase Santyl | $10 |
| Smith+Nephew | Meals · 2025-05-07 | Collagenase Santyl | $7 |
| MIMEDX Group | Meals · 2025-04-11 | None | $10 |
| Smith+Nephew | Meals · 2025-03-17 | Collagenase Santyl | $9 |
| Smith+Nephew | Meals · 2025-03-07 | Stravix Pl | $28 |
| MIMEDX Group | Meals · 2025-02-27 | None | $132 |
| MIMEDX Group | Meals · 2025-02-20 | None | $50 |
| MIMEDX Group | Meals · 2025-02-07 | None | $5 |
| MIMEDX Group | Meals · 2025-01-23 | None | $91 |
| Smith+Nephew | Meals · 2025-01-15 | Collagenase Santyl | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $326
| Smith+Nephew | Collagenase Santyl | $157 | 9 payments
|
| Medtronic | Intellis Adaptivestim | $68 | 2 payments
|
| MIMEDX Group | None | $42 | 2 payments
|
| Philips North America | (Ak6) Vest Therapy | $30 | 1 payment
|
| Baxter Healthcare | Hillrom - Monarch Airway Clearance System | $16 | 1 payment
|
| Nevro | Senza | $13 | 1 payment
|
2023: $21
| Averitas Pharma | Qutenza | $21 | 1 payment
|
2022: $102
| Treace Medical Concepts | Lapiplasty System | $81 | 1 payment
|
| Orthofix Medical | Physio-Stim | $21 | 1 payment
|
2021: $315
| Treace Medical Concepts | Lapiplasty System | $315 | 2 payments
|
2020: $59
| Arthrosurface | Hemicap Mtp Resurfacing | $59 | 1 payment
|
2019: $239
| Horizon Therapeutics plc | Krystexxa | $119 | 1 payment
|
| Zimmer Biomet Holdings | Scp Bone Substitute | $73 | 1 payment
|
| Paragon 28 | None | $35 | 1 payment
|
| Pfizer | Lyrica | $14 | 1 payment
|
Professional record
- NPI
- 1982627675
- Licence
- CA E4625
- Trained
- California School of Podiatric Medicine, 2003
- Group
- Golden Valley Health Centers · Provident Primary Care Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 737 W Childs Ave, Merced, CA, 95341
- NPI first listed
- 2006-07-25
- NPI last updated
- 2021-10-21
- NPI record certified
- 2021-10-21
This is when the NPI record was last certified, not a medical board exam.